share_log

荃信生物-B:(1) 2023年董事會工作報告;(2) 2023年監事會工作報告;(3) 2023年年度報告;(4) 2023年利潤分配方案;(5) 2024年董事及監事薪酬方案;(6) 委聘2024年審計師;(7) 建議授出發行H股的一般性授權;(8) 為一間附屬公司提供擔保;及2023年股東週年大會通告

QYUNS-B: (1) 2023 WORK REPORT OF THE BOARD(2) 2023 WORK REPORT OF THE BOARD OF SUPERVISORS(3) 2023 ANNUAL REPORT;(4) 2023 PROFIT DISTRIBUTION PLAN;(5) 2024 REMUNERATION SCHEME FOR DIRECTORS AND SUPERVISORS;(6) ENGAGEMENT OF THE AUDITOR FOR 2024;(7) PROPOSED G

HKEX ·  Apr 26, 2024 19:11
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more